Esperion Therapeutics, Inc.
US ˙ NasdaqGM ˙ US29664W1053

SecurityESPR / Esperion Therapeutics, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership3,031 shares
Latest Disclosed Value $ 8,305
Walleye Capital LLC ownership in ESPR / Esperion Therapeutics, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 3,031 shares of Esperion Therapeutics, Inc. (US:ESPR) valued at $8,305 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,569,216 shares of Esperion Therapeutics, Inc.. This represents a change in shares of -99.81% during the quarter. The current value of the position is $9,517 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (ESPR) in the form of stock options. The firm currently holds call options representing 11,900 of underlying shares valued at $32,606 USD and put options representing 14,600 of underlying shares valued at $40,004 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ESPR / Esperion Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 3,031 -1,566,185 -99.81 8 -99.86 0.0000
2026-05-08 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,031 -1,566,185 8 0.0000
2026-02-13 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 1,569,216 1,250,025 391.62 5,806 587.10 0.0178
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 319,191 319,191 846 0.0032
2025-05-14 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -80,837 -100.00 0 -100.00
2025-02-13 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 80,837 80,837 178 0.0004
2024-08-14 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -227,630 -100.00 0 -100.00
2024-05-15 2024-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 227,630 13,630 6.37 610 -4.54 0.0011
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 214,000 214,000 640 0.0014
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -12,296 -100.00 0 -100.00
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 12,296 12,296 20 0.0003
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -698,343 -100.00 0 -100.00
2022-11-14 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 698,343 -26,111 -3.60 4,679 1.54 0.0893
2022-08-19 2022-06-30 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 724,454 417,773 136.22 4,608 223.82 0.1270
2022-08-08 2022-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 724,454 417,773 4,608 0.1270
2022-05-27 2022-03-31 13F/A-01 ESPERION THERAPEUTICS INC NE COM 29664W105 306,681 145,932 90.78 1,423 76.99 0.0380
2022-05-16 2022-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 306,681 145,932 1,423 0.0290
2022-05-27 2021-12-31 13F/A-01 ESPERION THERAPEUTICS INC NE COM 29664W105 160,749 160,749 804 0.0250
2022-03-03 2021-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 160,749 160,749 804 0.0201
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -300 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 300 300 18 0.0012
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -529 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 529 529 25 0.0027
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A ESPERION THERAPEUTICS INC NE COM Call 11,900 -92.55 33 -94.58 n/a n/a n/a
2026-05-08 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 11,900 33 n/a n/a n/a
2026-02-13 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 159,700 119.37 591 207.29 n/a n/a n/a
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 72,800 193 n/a n/a n/a
2025-05-14 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 8,700 19 n/a n/a n/a
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 6,300 10 n/a n/a n/a
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 10,800 72 n/a n/a n/a
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM Call 29,200 -48.32 1,741 -15.93 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Call 56,500 1,561.76 2,071 1,210.76 n/a n/a n/a
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 3,400 -76.39 158 -72.66 n/a n/a n/a
2019-08-14 2019-03-31 13F/A ESPERION THERAPEUTICS INC NE COM Call 14,400 578 n/a n/a n/a
2019-05-15 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 14,400 578 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A ESPERION THERAPEUTICS INC NE COM Put 14,600 -91.72 40 -93.87 n/a n/a n/a
2026-05-08 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 14,600 40 n/a n/a n/a
2026-02-13 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 176,300 777.11 652 1,130.19 n/a n/a n/a
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 20,100 53 n/a n/a n/a
2025-05-14 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 18,900 42 n/a n/a n/a
2023-08-14 2023-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 n/a n/a n/a
2023-05-15 2023-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 500 1 n/a n/a n/a
2023-02-14 2022-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 13,800 92 n/a n/a n/a
2020-05-15 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM Put 23,600 -41.15 1,407 -4.29 n/a n/a n/a
2019-11-14 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM Put 40,100 2,984.62 1,470 2,350.00 n/a n/a n/a
2019-08-14 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM Put 1,300 -90.58 60 -89.17 n/a n/a n/a
2019-08-14 2019-03-31 13F/A ESPERION THERAPEUTICS INC NE COM Put 13,800 554 n/a n/a n/a
2019-05-15 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM Put 13,800 554 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.